Shares of Abbott Laboratories (ABT) are under pressure on Monday after Goldman Sachs analyst Amit Hazan downgraded the stock to Sell from Neutral as he believes shares have overreacted to the company’s COVID-19 testing opportunity. On the flip… To see the rest of the story go to thefly.com. (See Story Here):(https://www.thefly.com/permalinks/entry.php/id3103134/-Analyst-says-sell-Abbott-after-stock-overreacted-to-COVID-opportunity)
previous post